Background

The International Trade Commission has recently announced the following actions in intellectual property rights infringement investigations. For more information on pursuing or mitigating IPR-related import restrictions, please contact attorney Lee Sandler via email or at (305) 894-1000.

Adalimumab – termination without import restrictions of investigation 337-TA-1296 of the drug adalimumab, processes for manufacturing or relating to same, and products containing same

Container openers – issuance of general exclusion order in investigation 337-TA-1255 of apparatus and methods of opening containers

In vitro products – issuance of limited exclusion order and cease and desist order in investigation 337-TA-1196 of in vitro fertilization products, components thereof, and products containing the same

Pyraclostrobin – termination without import restrictions of investigation 337-TA-1303 of products containing pyraclostrobin (a fungicide) and components thereof based on consent order

Copyright © 2022 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 

Close

Cookie Consent

We use cookies on our website. By continuing to use our website, you agree to the Privacy Policy and Terms of Use.